Plain language summary of the MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma - Chari, Ajai (Mount Sinai School of Medicine, USA) ; Askari, Elham (Hospital Universitario Fundación Jiménez Díaz) ; Caers, Jo (Centre Hospitalier Universitaire de Liège, Belgium) ; Costa, Luciano J. (University of Alabama at Birmingham, USA) ; Hilder, Brandi W. (Janssen Research & Development, Spring House, USA) ; Krishnan, Amrita (City of Hope Comprehensive Cancer Center, Duarte, USA) ; Mateos, M. V (Hospital Universitario de Salamanca) ; Minnema, Monique C. (University Utrecht, Netherlands) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Pillarisetti, Kodandaram (Janssen Research & Development, Spring House, USA) ; Van De Donk, Niels W.C.J. (Vrije Universiteit Amsterdam, Netherlands) ; Rodríguez-Otero, Paula (Clínica Universidad de Navarra)
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.